Our R&D aim is to enhance and improve the life qualities of the patients around the globe.

2008

Initialization Research & Development and production of IOL pipeline.

2009

Acriva Monofocal IOL line launched.

2010

Multifocal IOLs developed - Acriva Reviol Multifocal IOL launched.

2010

Initialization hydrophobic IOL biomaterials.

2011

Blue light filtering IOLs developed - Acriva BB portfolio launched.

2011

Development of Toric IOLs - Acriva Toric line for monofocal and multifocal IOLs launched.

2013

Development of OVDs.

June 2014

Certified as “R&D Center” by the Turkish Ministry of Industry and Technology as the 161th R&D Center in Turkey and the first Biotechnology R&D Center.

September 2015

Rotary Pre-loaded Injector patent application filed.

August 2016

"Shrinkable injection cushion for intraocular lens” patent application filed

July 2017

Sinusoidal Vision Technology (SVT) patent application filed

January 2019

“2244-Industrial PhD Program” funded by The Turkish Scientific and Technological Research Council of Turkey (TÜBİTAK) in collaboration with Sabancı University Nanotechnology Research and Application Center (SUNUM) funding 3 PhD candidates in the fields of new biotech products and processes

March 2019

Industrial Innovation Networks Mechanism (SAYEM) Program funded by The Turkish Scientific and Technological Research Council of Turkey (TÜBİTAK) forming a consortium with 7 academic institutions and SMEs.

September 2019

Rotary Pre-loaded Injector patent granted by EPO in Europe.

January 2020

Protein-based original drug development research project started in collaboration with Turkish academic institution Izmir Biomedicine and Genome Center.

May 2020

Rotary Pre-loaded Injector patent granted by USPTO in US.

April 2020

Sinusoidal Vision Technology (SVT) patent granted by EPO in Europe.

September 2020

In the ISIF’20 İstanbul International Inventions Fair; 8 Patents were awarded, including “IFIA Best National”, 3 Gold, 3 Silver and 1 Bronze medals.

September 2020

Rotary Pre-loaded Injector patent granted by JPO in Japan.

April 2021

Honored as 2021 Medical Design Excellence Awards (MDEA) Finalist.

May 2021

Enova GF3 C Loop: 100% Glistening-Free IOL launched.

October 2021

The first and only trifocal presbyopia-correcting IOL) with patented enhanced Sinusoidal Vision Technology: the AcrivaUD Trinova Pro C Pupil Adaptive® was launched

October 2021

Acrivaᵁᴰ Trinova Pro C Pupil Adaptive® has been nominated for the 2022 Edison Awards.

April 2021

Rotary Pre-loaded Injector patent granted by KIPO in South Korea.

December 2021

Sinusoidal Vision Technology (SVT) patent granted by CNIPA in China.